Literature DB >> 8275386

Systemic and local factors and the maintenance of bone quality.

E Canalis1.   

Abstract

Bone formation, an essential process for the maintenance of bone mass and strength, depends on changes in osteoblast number or function. Bone formation is modified by systemic hormones such as parathyroid hormone, growth hormone, insulin and steroids, and by local factors that act in an antocrine or paracrine fashion on the osteoblast. Skeletal cells synthesize platelet-derived growth factors and fibroblast growth factors, agents which affect osteoblast cell replication. In addition, skeletal cells synthesize insulin-like growth factors and transforming growth factors beta, agents which also affect the differentiated function of the osteoblast. Systemic and local factors that modify bone formation are likely critical in the maintenance of normal bone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8275386     DOI: 10.1007/bf01673411

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

Review 1.  Growth factors and cytokines in bone cell metabolism.

Authors:  E Canalis; T L McCarthy; M Centrella
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

Review 2.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset.

Authors:  J M Kaufman; P Taelman; A Vermeulen; M Vandeweghe
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

Review 4.  The cell biology of transforming growth factor beta.

Authors:  J A Barnard; R M Lyons; H L Moses
Journal:  Biochim Biophys Acta       Date:  1990-06-01

5.  Insulin-like growth factor I has independent effects on bone matrix formation and cell replication.

Authors:  J M Hock; M Centrella; E Canalis
Journal:  Endocrinology       Date:  1988-01       Impact factor: 4.736

Review 6.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

7.  Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.

Authors:  T L McCarthy; M Centrella; E Canalis
Journal:  Endocrinology       Date:  1990-03       Impact factor: 4.736

8.  Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.

Authors:  R Civitelli; K A Hruska; J J Jeffrey; A J Kahn; L V Avioli; N C Partridge
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

9.  Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.

Authors:  E Canalis
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

10.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  4 in total

Review 1.  Bone mineral density in acromegaly: does growth hormone excess protect against osteoporosis?

Authors:  I Chiodini; V Trischitta; V Carnevale; A Liuzzi; A Scillitani
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

2.  Differential Age-related Changes in Bone Geometry between the Humerus and the Femur in Healthy Men.

Authors:  Matti D Allen; S Jared McMillan; Cliff S Klein; Charles L Rice; Greg D Marsh
Journal:  Aging Dis       Date:  2011-09-22       Impact factor: 6.745

3.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

4.  Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat.

Authors:  G N Mann; D A Sass; H K Chen; F J Buchinsky; H P Bryer; Y F Ma; W S Jee; B Rucinski; S Epstein
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.